Ecora Resources PLC is engaged in obtaining royalties from a diversified portfolio focusing on base metals and bulk materials. It focuses on commodities such as Copper; Nickel; Iron Ore; Gold; Cobalt; Vanadium; Met Coal and Uranium. Some of its assets include Voisey's Bay; Mantos Blancos; Maracas Menchen and others.
相关临床试验
19
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
已完成
12
63.2%
终止
4
21.1%
撤回
3
15.8%
暂无批准数据
- A Phase 1 trial of implanted vagus nerve stimulation paired with prolonged exposure therapy achieved 100% loss of PTSD diagnosis in all nine participants, with benefits persisting for six months after treatment completion. - The study represents the largest clinical trial to date using an implanted device for PTSD treatment, building on 13 years of VNS research that previously gained FDA approval for stroke rehabilitation. - A separate pilot study has begun testing electroCore's non-invasive gammaCore device in 40 PTSD patients, exploring a less invasive approach to vagus nerve stimulation for psychiatric applications. - Both trials address significant unmet medical needs, as many PTSD patients fail to respond to traditional therapy or pharmacological interventions, with current gold-standard treatments showing only 40% diagnostic remission rates.
- A peer-reviewed study published in Frontiers in Neurology demonstrates that gammaCore non-invasive vagus nerve stimulation, when used with standard care, significantly reduced persistent symptoms in 102 patients with mild traumatic brain injury. - Patients experienced significant improvements in 16 of 22 symptom categories including post-traumatic headache, dizziness, difficulty concentrating, and depression, with 34% reporting meaningful improvement in at least half of their symptoms. - The treatment showed effectiveness regardless of time since injury, benefiting both patients treated within three months and those with symptoms persisting over a year, with no device-related adverse events reported. - This represents the first relatively large prospective study demonstrating the potential of non-invasive vagus nerve stimulation for treating multiple persistent traumatic brain injury symptoms.
